A functional classification scheme for beta-lactamases and its correlation with molecular structure. K Bush, GA Jacoby, AA Medeiros Antimicrobial agents and chemotherapy 39 (6), 1211, 1995 | 4848 | 1995 |
Updated functional classification of β-lactamases K Bush, GA Jacoby Antimicrobial agents and chemotherapy 54 (3), 969-976, 2010 | 3902 | 2010 |
Carbapenemases: the versatile β-lactamases AM Queenan, K Bush Clinical microbiology reviews 20 (3), 440-458, 2007 | 3871 | 2007 |
Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae (vol 45, pg 1151, 2001) H Yigit, AM Queenan, GJ Anderson, A Domenech-Sanchez, JW Biddle, ... Antimicrobial Agents and Chemotherapy 52 (2), 809-809, 2008 | 2513* | 2008 |
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae H Yigit, AM Queenan, GJ Anderson, A Domenech-Sanchez, JW Biddle, ... Antimicrobial agents and chemotherapy 45 (4), 1151-1161, 2001 | 2486 | 2001 |
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase A Robicsek, J Strahilevitz, GA Jacoby, M Macielag, D Abbanat, ... Nature medicine 12 (1), 83-88, 2006 | 1502 | 2006 |
β-Lactams and β-lactamase inhibitors: an overview K Bush, PA Bradford Cold Spring Harbor perspectives in medicine 6 (8), a025247, 2016 | 1409 | 2016 |
Tackling antibiotic resistance K Bush, P Courvalin, G Dantas, J Davies, B Eisenstein, P Huovinen, ... Nature Reviews Microbiology 9 (12), 894-896, 2011 | 1319 | 2011 |
Past and present perspectives on β-lactamases K Bush Antimicrobial agents and chemotherapy 62 (10), e01076-18, 2018 | 999 | 2018 |
Epidemiology of β-lactamase-producing pathogens K Bush, PA Bradford Clinical microbiology reviews 33 (2), 10.1128/cmr. 00047-19, 2020 | 801 | 2020 |
New β-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy GM Eliopoulos, K Bush Clinical Infectious Diseases 32 (7), 1085-1089, 2001 | 768 | 2001 |
Multiple antibiotic–resistant Klebsiella and Escherichia coli in nursing homes J Wiener, JP Quinn, PA Bradford, RV Goering, C Nathan, K Bush, ... Jama 281 (6), 517-523, 1999 | 760 | 1999 |
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. PA Bradford, C Urban, N Mariano, SJ Projan, JJ Rahal, K Bush Antimicrobial agents and chemotherapy 41 (3), 563-569, 1997 | 737 | 1997 |
Carbapenem-hydrolyzing beta-lactamases BA Rasmussen, K Bush Antimicrobial agents and chemotherapy 41 (2), 223-232, 1997 | 687 | 1997 |
Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria K Bush, JF Fisher Annual review of microbiology 65, 455-478, 2011 | 670 | 2011 |
Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae K Bush Current opinion in microbiology 13 (5), 558-564, 2010 | 670 | 2010 |
Characterization of beta-lactamases K Bush Antimicrobial agents and chemotherapy 33 (3), 259-263, 1989 | 618 | 1989 |
Interplay between β-lactamases and new β-lactamase inhibitors K Bush, PA Bradford Nature Reviews Microbiology 17 (5), 295-306, 2019 | 522 | 2019 |
Interplay between β-lactamases and new β-lactamase inhibitors K Bush, PA Bradford Nature Reviews Microbiology 17 (5), 295-306, 2019 | 522 | 2019 |
Interplay between β-lactamases and new β-lactamase inhibitors K Bush, PA Bradford Nature Reviews Microbiology, 1, 2019 | 522 | 2019 |